Home / Newsroom / Engineering Consultation: In-House Pilot Packaging Lines vs. Contract Repackaging (UK)
Engineering Consultation: In-House Pilot Packaging Lines vs. Contract Repackaging (UK)
02/06/2018
Project Overview: A UK-based healthcare supplement company recently contacted JORNEN regarding a pilot scheme for a new product launch. While the client initially inquired about contract packaging services (CMO) to repackage bulk capsules into blisters and cartons, this presented a perfect opportunity for an engineering consultation. As a pharmaceutical equipment manufacturer, JORNEN advised the client on the strategic and economic advantages of establishing a compact, in-house R&D packaging line instead of outsourcing micro-batches.
1. Pilot-Scale Production Parameters
The client’s market trial involves low-volume, high-mix repackaging with very specific batch requirements:
Micro-Batch Volumes: Initial trial runs consist of exceptionally small capacities—specifically 6,000 capsules (equivalent to 100 bottles) and 12,000 capsules (200 bottles).
Format Flexibility: The primary packaging module must be capable of frequent, low-cost format changeovers to accommodate varying blister configurations of 6, 8, and 10 capsules per individual blister card.
2. Secondary Packaging & Cartoning Integration
For the secondary packaging phase, the client provides custom digital artwork and structural designs. The requirement calls for a flexible cartoning solution capable of feeding pre-printed flat carton blanks, erecting them, and seamlessly inserting the multiple blister formats along with any necessary literature, all while maintaining high precision for market-facing presentation.
3. Strategic Engineering Solution
Contracting third-party CMO services for volumes as low as 6,000 capsules often incurs disproportionately high setup and mold fees. JORNEN’s technical sales team proposed an alternative Capex strategy: investing in an entry-level, small-footprint blister and cartoning setup (such as our R&D-focused laboratory series). This empowers the client to execute agile market testing internally, protect their intellectual property, and seamlessly transition to larger commercial volumes using the exact same operational logic.
Project Status: JORNEN is currently preparing a detailed capital expenditure (CAPEX) quotation for a compact pilot-line equipment package. This includes the bespoke tooling costs for the 6, 8, and 10-capsule blister formats, alongside detailed shipping logistics to Surrey, UK.